Atazanavir for HIV Infected Individuals: An Early Access Program
The purpose of this clinical research study is to provide atazanavir to patients infected with human immunodeficiency virus (HIV) whose antiviral medications are no longer working to control HIV activity within the body and who are unable to create a new treatment regimen using other available anti-HIV drugs, because of either side effects or treatment failure previously taken. The safety of this treatment will also be studied.
|Study Type:||Expanded Access What is Expanded Access?|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00046345
Show 165 Study Locations